Stay updated on SCT: Lisdexamfetamine Trial for ADHD & SCT
Sign up to get notified when there's something new on the SCT: Lisdexamfetamine Trial for ADHD & SCT page.

Latest updates to the SCT: Lisdexamfetamine Trial for ADHD & SCT page
- CheckyesterdayChange DetectedThe updates appear to be minor visual/layout changes to the Study Details page with no modifications to core trial content such as eligibility criteria, interventions, or primary outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check29 days agoChange DetectedMajor update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check37 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the previous version tag v3.0.2 as background.SummaryDifference0.5%

- Check51 days agoChange DetectedThe page revision has updated from v3.0.1 to v3.0.2. The 'Back to Top' link has been removed.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated to include new information about drug safety and specific drugs like dextroamphetamine and amphetamines, while removing several terms related to neurological conditions and previous drug classifications.SummaryDifference4%

Stay in the know with updates to SCT: Lisdexamfetamine Trial for ADHD & SCT
Enter your email address, and we'll notify you when there's something new on the SCT: Lisdexamfetamine Trial for ADHD & SCT page.